Authors: Sperber, AD Carmel, S Atzmon, Y Weisberg, I Shalit, Y Neumann, L Fich, A Friger, M Buskila, D

Citation: Ad. Sperber et al., Use of the Functional Bowel Disorder Severity Index (FBDSI) in a study of patients with the irritable bowel syndrome and fibromyalgia, AM J GASTRO, 95(4), 2000, pp. 995-998

Authors: Sibani, S Leclere, D Weisberg, I Rozen, R

Citation: S. Sibani et al., The silent T1317C mutation of methylenetetrahydrofolate reductase should not interfere with Mboll restriction isotyping of the reported A1298C mutation - Reply, MOL GEN MET, 68(4), 1999, pp. 512-512

Authors: Sperber, AD Weisberg, I Skibin, A Neumann, L Fich, A Buskila, D

Citation: Ad. Sperber et al., Serum interleukin-1, interleukin-2, interleukin-6, and prolactin levels are not associated with the severity of disease in patients with the irritable bowel syndrome, with or without concomitant fibromyalgia, J MUSCULO P, 7(4), 1999, pp. 15-27

Authors: Sperber, AD Carmel, S Atzmon, Y Weisberg, I Shalit, Y Neumann, L Fich, A Buskila, D

Citation: Ad. Sperber et al., The Sense of Coherence index and the irritable bowel syndrome - A cross-sectional comparison among irritable bowel syndrome patients with and withoutcoexisting fibromyalgia, irritable bowel syndrome non-patients, and controls, SC J GASTR, 34(3), 1999, pp. 259-263

Authors: Sperber, AD Atzmon, Y Neumann, L Weisberg, I Shalit, Y Abu-Shakrah, M Fich, A Buskila, D

Citation: Ad. Sperber et al., Fibromyalgia in the irritable bowel syndrome: Studies of prevalence and clinical implications, AM J GASTRO, 94(12), 1999, pp. 3541-3546